- Home
- CMPX vs MTA Comparison
CMPX vs MTA Comparison
Compare CMPX & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- MTA
- Stock Information
- Founded
- CMPX 2014
- MTA 1983
- Country
- CMPX United States
- MTA Canada
- Employees
- CMPX N/A
- MTA N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- MTA
- Sector
- CMPX Health Care
- MTA
- Exchange
- CMPX Nasdaq
- MTA Nasdaq
- Market Cap
- CMPX 236.7M
- MTA 237.9M
- IPO Year
- CMPX N/A
- MTA N/A
- Fundamental
- Price
- CMPX $1.38
- MTA $2.85
- Analyst Decision
- CMPX Strong Buy
- MTA
- Analyst Count
- CMPX 3
- MTA 0
- Target Price
- CMPX $7.67
- MTA N/A
- AVG Volume (30 Days)
- CMPX 513.3K
- MTA 429.0K
- Earning Date
- CMPX 11-12-2024
- MTA 11-22-2024
- Dividend Yield
- CMPX N/A
- MTA N/A
- EPS Growth
- CMPX N/A
- MTA N/A
- EPS
- CMPX N/A
- MTA N/A
- Revenue
- CMPX $850,000.00
- MTA $5,048,000.00
- Revenue This Year
- CMPX N/A
- MTA $44.57
- Revenue Next Year
- CMPX $747.71
- MTA $126.18
- P/E Ratio
- CMPX N/A
- MTA N/A
- Revenue Growth
- CMPX N/A
- MTA 28.55
- 52 Week Low
- CMPX $0.77
- MTA $2.32
- 52 Week High
- CMPX $2.34
- MTA $4.08
- Technical
- Relative Strength Index (RSI)
- CMPX 31.85
- MTA 32.20
- Support Level
- CMPX $1.74
- MTA $3.26
- Resistance Level
- CMPX $2.00
- MTA $3.73
- Average True Range (ATR)
- CMPX 0.14
- MTA 0.18
- MACD
- CMPX -0.04
- MTA -0.10
- Stochastic Oscillator
- CMPX 6.06
- MTA 2.30
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About MTA Metalla Royalty & Streaming Ltd.
Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.